Carbadox is a veterinary medicine, which was approved by FDA for the treatment of swine dysentery and bacterial swine enteritis. In 2016 the FDA announced its plans to withdraw the approval of Mecadox (carbadox) due to the concern that the drug may leave trace amounts of carcinogenic residue in pork that could pose a cancer risk to people, however, the drug is still marketing.